Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide Premedication in Upper GI Bleeds
NCT05746377Phase 4Unknown
- Sponsor
- Mercy Health System
- Start
- May 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metoclopramide in upper gastrointestinal bleeding (UGIB), sponsored by Mercy Health System. Status: unknown.
02
Drugs
metoclopramide
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT05746377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05746377.